For the past several months, we have been finalising the first usable release of a system that we think would remedy some high-impact pain points we have seen in working with data in high-paced bio- and med-tech companies.
Health and clinical data is a central part of understanding the reality of dealing with diseases. The need for it only increases while the access-related challenges make it complicated to acquire. Thankfully due to a recent effort by HDRUK, more and more datasets can be shared.
There is an unprecedented demand for biomedical data both for research and application, driven by the availability of large-scale processing technology and the resurgence of predictive modelling / AI. Given the vast amount of possible sources, how does one know which one they should be using?